Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Antibacterial
    (1)
  • Apoptosis
    (1)
  • Chk
    (1)
  • Endogenous Metabolite
    (1)
  • Ligands for E3 Ligase
    (1)
  • Microtubule Associated
    (1)
  • PPAR
    (1)
  • Parasite
    (1)
  • iGluR
    (1)
  • Others
    (2)
TargetMol | Tags By ResearchField
  • Nervous System
    (2)
  • Cancer
    (1)
  • Infection
    (1)
  • Metabolism
    (1)
Filter
Search Result
Results for "

D 301

" in TargetMol Product Catalog.
  • Inhibitors & Agonists
    8
    TargetMol | All_Pathways
  • PROTAC Products
    1
    TargetMol | PROTAC
  • Recombinant Protein
    5
    TargetMol | Recombinant_Protein
  • Antibody Products
    3
    TargetMol | Antibody_Products
  • Benzoxonium chloride
    D301, D 301, Cohortan, Bradophen, Bialcol
    T2378319379-90-9
    Benzoxonium chloride, The topical treatment of anthroponotic cutaneous leishmaniasis with the tincture of thioxolone plus benzoxonium chloride (Thio-Ben) along with cryotherapy.
    • $1,520
    6-8 weeks
    Size
    QTY
  • KD-3010
    T11747934760-92-6In house
    KD-3010 (Kalypsys) is an orally active potent and selective PPARδ agonist for the study of liver injury.
    • $1,820
    8-10 weeks
    Size
    QTY
  • 2-Methyl-1,2,3,4-tetrahydro-acridine-9-carboxylic acid
    TPL0458247571-77-3
    2-Methyl-1,2,3,4-tetrahydro-acridine-9-carboxylic acid ,with CAS No. 247571-77-3, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 2-Methyl-1,2,3,4-tetrahydro-acridine-9-carboxylic acid provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.
    • $35
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
  • D3017
    T204154130403-18-8
    D3017, the primary alcohol metabolite of D2624, is orally active and possesses anticonvulsant properties. It has an ED50 value of 1.5 mg/kg in mice, and is applicable for studies on severe generalized tonic-clonic (grand mal) seizures and complex partial epilepsy.
    • Inquiry Price
    10-14 weeks
    Size
    QTY
  • CRBN ligand-301
    T2162962925102-81-2
    CRBN ligand-301 is an E3 ubiquitin ligase cereblon (CRBN) ligand designed for recruiting cereblon proteins. It can be attached via a linker to a target protein ligand to form a PROTAC.
    • Inquiry Price
    Inquiry
    Size
    QTY
  • KD3010 tosylate
    T68302934760-90-4
    KD-3010 is a peroxisome proliferator-activated receptor delta agonist potentially for the treatment of diabetes and obesity. KD-3010 dramatically ameliorates liver injury induced by carbon tetrachloride (CCl(4)) injections. Deposition of extracellular matrix proteins was lower in the KD3010-treated group than in the vehicle- or GW501516-treated group. Interestingly, profibrogenic connective tissue growth factor was induced significantly by GW501516, but not by KD-3010, following CCl(4) treatment.
    • $1,670
    6-8 weeks
    Size
    QTY
  • Rislenemdaz
    MK-0657, CERC-301
    T12733808732-98-1
    Rislenemdaz (CERC-301) (CERC-301) is an antagonist of the N-methyl-D-aspartate (NMDA) receptor subunit 2B (GluN2B).
    • $59
    In Stock
    Size
    QTY
  • Indibulin
    ZIO 301, D 24851
    T15576204205-90-3
    Indibulin (D 24851) is a synthetic small molecule with antimitotic and potential antineoplastic activities.Indibulin an orally applicable inhibitor of tubulin assembly, shows potent anticancer activity with a minimal neurotoxicity. Indibulin reduces inter-kinetochoric tension, produces aberrant spindles, activates mitotic checkpoint proteins Mad2 and BubR1, and induces mitotic arrest and apoptosis.
    • $35
    In Stock
    Size
    QTY